Reference
1. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System, 4th ed. 2010.
2. Classification of Tumours Editorial Board. WHO Classification of Tumours of the Digestive System, 5th ed. 2019.
3. Applebaum EL, Mantravadi P, Haas R. Lymphoepithelioma of the nasopharynx. Laryngoscope 1982; 92: 510-514.
4. Elliot DRF, Gill RM. Undifferentiated variant. In: Gastrointestinal Pathology, Edited by Gonzalez RS, Volume 13-3, 2019.
5. Iezzoni JC, Gaffey MJ, Weiss LM. The Role of Epstein-Barr Virus in Lymphoepithelioma-like Carcinomas. Am J Clin Pathol 1995; 103: 308-315.
6. Labgaa I, Stueck A, Ward SC. Lymphoepithelioma-Like Carcinoma in Liver. Am J Pathol 2017; 187: 1438-1444.
7. Putra J, Anderson TA, Roayaie S, Maeda M, Thung SN. Metastatic lymphoepithelioma-like hepatocellular carcinoma: A potential diagnostic pitfall and demonstration of Pd-l1 expression. Annals of Hepatology 2017; 16: 157-159.
8. Shirabe K, Matsumata T, Maeda T, Sadanaga N, Kuwano H, Sugimachi K. A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration - A clinicopathological study.Hepatogastroenterology 1995; 42: 996-1001.
9. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 1998; 27: 407-414.
10. Emile JF, Adam R, Sebagh M, et al. Hepatocellular carcinoma with lymphoid stroma: A tumour with good prognosis after liver transplantation. Histopathology 2000; 37: 523-529.
11. Si MW, Thorson JA, Lauwers GY, DalCin P, Furman J. Hepatocellular lymphoepithelioma-like carcinoma associated with Epstein Barr virus: A Hitherto unrecognized entity. Diagn Mol Pathol 2004; 13: 183-189.
12. Chen CJ, Jeng L Bin, Huang SF. Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J 2007; 30: 172-177.
13. Nemolato S, Fanni D, Naccarato AG, Ravarino A, Bevilacqua G, Faa G. Lymphoepitelioma-like hepatocellular carcinoma: A case report and a review of the literature. World J Gastroenterol 2008; 14: 4694-4696.
14. Park HS, Jang KY, Kim YK, Cho BH, Moon WS. Hepatocellular carcinoma with massive lymphoid infiltration: A regressing phenomenon?Pathol Res Pract 2009; 205: 648-652.
15. Shinoda M, Kadota Y, Tsujikawa H, et al. Lymphoepithelioma-like hepatocellular carcinoma: A case report and a review of the literature.World J Surg Oncol 2013; 11: 97.
16. Patel KR, Liu TC, Vaccharajani N, Chapman WC, Brunt EM. Characterization of inflammatory (lymphoepithelioma-like) hepatocellular carcinoma: A study of 8 cases. Arch Pathol Lab Med 2014; 138: 1193-1202.
17. An SL, Liu LG, Zheng YL, et al. Primary lymphoepithelioma-like hepatocellular carcinoma: Report of a locally advanced case and review of literature. Int J Clin Exp Pathol 2015; 8: 3282-3287.
18. Chan AWH, Tong JHM, Pan Y, et al. Lymphoepithelioma-like hepatocellular carcinoma: An uncommon variant of hepatocellular carcinoma with favorable outcome. Am J Surg Pathol 2015; 39: 304-312.
19. Insilla AC, Faviana P, Pollina LE, et al. Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature.World J Gastroenterol 2015; 21: 10468-10474.
20. Wei J, Liu Q, Wang C, Yu S. Lymphoepithelioma-like hepatocellular carcinoma without Epstein-Barr virus infection: A case report and a review of the literature. Indian J Pathol Microbiol 2015; 58: 550-553.
21. Miyasaka C, Ishida M, Ito H, Kaibori M, Uemura Y, Tsuta K. Lymphoepithelioma-like hepatocellular carcinoma: A case report with emphasis on the cytological features. Int J Clin Exp Pathol 2017; 10: 7893-7897.
22. Wang JK, Jin YW, Hu HJ, et al. Lymphoepithelioma-like hepatocellular carcinoma. A case report and brief review of literature. Medicine2017; 96: e9416.
23. Shih EJ, Chau IY, Yeh YC, Chau GY. Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver: A case report. Medicine 2018; 97: e12548.
24. Filotico M, Moretti V, Floccari F, D’Amuri A. Very Rare Liver Neoplasm: Lymphoepithelioma-Like (LEL) Hepatocellular Carcinoma .Case Rep Pathol 2018; 2018: 2651716.
25. Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med 2020; 382: 1894-1905.
26. Chan AWH, Zhang Z, Chong CCN, Tin EKY, Chow C, Wong N. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma. J Pathol 2019; 249: 166-172.
27. Kim C, Rajan A, DeBrito PA, Giaccone G. Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: A case report and focused review of literature. Translational Lung Cancer Research 2016; 5: 720-726.
28. Kumar V, Dave V, Harris J, Huang Y. Response of advanced stage recurrent lymphoepithelioma-like carcinoma to nivolumab.Immunotherapy 2017; 9: 955-961.
29. Calderaro J, Rousseau B, Amaddeo G, et al. Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship with clinical and pathological features. Hepatology 2016; 64: 2038-2046.
30. Hartley GP, Chow L, Ammons DT, Wheat WH, Dow SW. Programmed cell death ligand 1 (PD-L1) signaling regulates macrophage proliferation and activation. Cancer Immunology Research 2018; 6: 1260-1273.